A company can have revenue and even sustainable re
Post# of 22467
(Total Views: 227)
Posted On: 02/10/2021 1:53:19 PM
A company can have revenue and even sustainable revenue BEFORE SEC Reports that cause the stock to rise. Reporting is incidental to the goal of uplisting. It's necessary but it's needed only to clear the field for the application to uplist to a better exchange.
Do companies apply to NASDAQ or the NYSE straight from being private companies,? YES. Therefore, QMC can apply for admission to those exchanges without being current with the OTC.
Audited financials; yes.
Current with OTC, not necessary.
The stock rise is contingent upon QMC'S gaining new business through any of these channels ,-
Possible paths to $2 or $3 dollars to meet conditions to uplist:
1. Because the deal with Pasaca is non-exclusive, new test manufsacturer clients for QMC HealthID can expand the ecosystem.
2. huge sales of bundled tests with Innova.
3. Disruptive Nanotechnologies that can be new products quickly for fat license fees and future royalties. QDLED, SOLAR, DISPLAYS. Check the QMC website.
4. Joint Ventures in other vertical industries needing DLT Blockchain, quantum dots and/or anticounterfeiting.
Very likely since we've done one already.
5 A stock buyback to lower the float.
Being nonreporting has not stopped QMC from doing business at all has it? QMC has signed up test manufacturers themselves and other ecosystem partners in conjunction with Innova. None have required SEC reporting as a condition of doing business, until this deal with Innova which does not mandate reporting specifically, but that "QMC shall give best efforts" and cause uplisting to happen to gain the best of the deal by March 31st.
The future will be here sooner than you think.
We're at minus 50 days and counting.
Do companies apply to NASDAQ or the NYSE straight from being private companies,? YES. Therefore, QMC can apply for admission to those exchanges without being current with the OTC.
Audited financials; yes.
Current with OTC, not necessary.
The stock rise is contingent upon QMC'S gaining new business through any of these channels ,-
Possible paths to $2 or $3 dollars to meet conditions to uplist:
1. Because the deal with Pasaca is non-exclusive, new test manufsacturer clients for QMC HealthID can expand the ecosystem.
2. huge sales of bundled tests with Innova.
3. Disruptive Nanotechnologies that can be new products quickly for fat license fees and future royalties. QDLED, SOLAR, DISPLAYS. Check the QMC website.
4. Joint Ventures in other vertical industries needing DLT Blockchain, quantum dots and/or anticounterfeiting.
Very likely since we've done one already.
5 A stock buyback to lower the float.
Being nonreporting has not stopped QMC from doing business at all has it? QMC has signed up test manufacturers themselves and other ecosystem partners in conjunction with Innova. None have required SEC reporting as a condition of doing business, until this deal with Innova which does not mandate reporting specifically, but that "QMC shall give best efforts" and cause uplisting to happen to gain the best of the deal by March 31st.
The future will be here sooner than you think.
We're at minus 50 days and counting.
(0)
(0)